Netherlands · Bentham Science Publishers B...

workspace_premium Q3 — Medicine (miscellaneous) lock Subscription

Recent Patents on Anti-Infective Drug Discovery

Recent Patents on Anti-Infective Drug Discovery is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 30. It has a best quartile of Q3.

ISSN: 1574-891X

Publisher: Bentham Science Publishers B.V.

Category: Medicine (miscellaneous)

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD Q3

H-index 30

Acceptance rate pie_chart

36%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

Docs (year)

Docs 3y

Total refs

391

Cites 3y

Citable 3y

Cites/Doc 2y

1,75

Ref/Doc

3258.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Current and Emerging Antivirals for the Treatment of Cytomegalovirus (CMV) Retinitis: an Update on Recent Patents

XDR-TB, What is it; How is it Treated; and why is Therapeutic Failure so High?

Global Clinical Trials for the Treatment of TB with Thioridazine

Geographical and Occupational Aspects of Leptospirosis in the Coffee-Triangle Region of Colombia, 2007-2011

Foreword

Emerging Drugs for the Treatment of Human Immunodeficiency Virus

Effective Therapy with the Neuroleptic Thioridazine as an Adjunct to Second Line of Defence Drugs, and the Potential that Thioridazine Offers for New Patents that Cover a Variety of "New Uses"

Editorial (Thematic Issue: Challenges for Fish Foodborne Parasitic Zoonotic Diseases (Part II))

Drug Effects on Drug Targets: Inhibition of Enzymes by Neuroleptics, Antimycotics,Antibiotics and Other Drugs on Human Pathogenic Amoebas and their Antiproliferative Effects

Direct Modification of Bioactive Phenothiazines by Exposure to Laser Radiation

Dendrimer Based Anti-Infective and Anti-Inflammatory Drugs

Cytokines as Immunomodulators in Tuberculosis Therapy

SHOW MORE ARTICLES

Current Status of Newer Antiinfectives

A Review of Anti-Parasitic Patents (1988-2008)

Complement 3 Receptor Expression in Individuals with Type 2 Diabetes

Commercial Development and Application of Type A Lantibiotics

Burkholderia mallei and Burkholderia pseudomallei: The Causative Micro-organisms of Glanders and Melioidosis

Biological Efficacy of Carvacrol Analogues

Bibliometric Assessment of the Contributions of Literature on Chagas Disease in Latin America and the Caribbean

Author Index To Volume 1

Antifungal Drug Discovery, Six New Molecules Patented After 10 Years of Feast:Why do we Need New Patented Drugs Apart from New Strategies?

Antibiotic Treatment Strategies for Helicobacter pylori Infection

Anti-Infective Quinone Derivatives of Recent Patents

Advances in the Development of Inactivated Virus Vaccines

FAQs

SJR is not available (NPD) for Recent Patents on Anti-Infective Drug Discovery in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Recent Patents on Anti-Infective Drug Discovery is 36%.

Recent Patents on Anti-Infective Drug Discovery

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Recent Patents on Anti-Infective Drug Discovery?

What is the APC / publication cost?

What is the acceptance rate?